The Open Payments program promotes transparency by making available to the public the financial relationships that physicians and teaching hospitals have with applicable manufacturers and group purchasing organizations. Although these financial relationships may provide important opportunities to increase medical research and enhance medical knowledge, they also can raise concerns because of their potential to influence the decision-making of health care providers. The transparency of the Open Payments program reveals the nature and extent of these relationships and has the potential to discourage the development of inappropriate financial relationships. However, the program can benefit the public only if the data reported are complete and accurate.
Report File
Date Issued
Submitting OIG
Department of Health & Human Services OIG
Other Participating OIGs
Department of Health & Human Services OIG
Agencies Reviewed/Investigated
Department of Health & Human Services
Report Number
OEI-03-15-00220
Report Description
Report Type
Inspection / Evaluation
Agency Wide
Yes
Number of Recommendations
4
Additional Details
Open Recommendations
This report has 1 open recommendations.
Recommendation Number | Significant Recommendation | Recommended Questioned Costs | Recommended Funds for Better Use | Additional Details | |
---|---|---|---|---|---|
5653 | No | $0 | $0 | ||
CMS should ensure that valid national drug codes are reported for drugs. |